C09B26/02

Organic dyes comprising a hydrazone moiety and their use in dye-sensitized solar cells

The present invention relates to compounds of general formula I ##STR00001##
wherein R.sup.100 and R.sup.200 are each independently hydrogen, C.sub.1-C.sub.10-alkyl which in case of C.sub.2-alkyl may be interrupted by one and in case of C.sub.3-C.sub.10-alkyl by one or two nonadjacent oxygen atoms, C.sub.5-C.sub.7-cycloalkyl, aryl, aryl-C.sub.1-C.sub.10-alkyl or aryloxy-C.sub.1-C.sub.10-alkyl, D is an m-valent (m=1, 2 or 3) donor moiety which comprises at least one carbon-carbon or carbon-heteroatom double bond and/or at least one unfused or fused carbo- or heterocyclic ring, A is an acceptor moiety which comprises at least one carbon-carbon or carbon-heteroatom double bond and/or at least one unfused or fused carbo- or heterocyclic ring, and the donor moiety D and the acceptor moiety A are π-conjugated to one another. Furthermore, the present invention relates to the use of compounds of formula I for producing dye-sensitized solar cells and to dye-sensitized solar cells comprising compounds of formula I.

Organic dyes comprising a hydrazone moiety and their use in dye-sensitized solar cells

The present invention relates to compounds of general formula I ##STR00001##
wherein R.sup.100 and R.sup.200 are each independently hydrogen, C.sub.1-C.sub.10-alkyl which in case of C.sub.2-alkyl may be interrupted by one and in case of C.sub.3-C.sub.10-alkyl by one or two nonadjacent oxygen atoms, C.sub.5-C.sub.7-cycloalkyl, aryl, aryl-C.sub.1-C.sub.10-alkyl or aryloxy-C.sub.1-C.sub.10-alkyl, D is an m-valent (m=1, 2 or 3) donor moiety which comprises at least one carbon-carbon or carbon-heteroatom double bond and/or at least one unfused or fused carbo- or heterocyclic ring, A is an acceptor moiety which comprises at least one carbon-carbon or carbon-heteroatom double bond and/or at least one unfused or fused carbo- or heterocyclic ring, and the donor moiety D and the acceptor moiety A are π-conjugated to one another. Furthermore, the present invention relates to the use of compounds of formula I for producing dye-sensitized solar cells and to dye-sensitized solar cells comprising compounds of formula I.

FLUORESCENT SCHIFF BASE CONJUGATE CU(II) CHEMOSENSORS AND METHODS THEREOF

Fluorescent Schiff base compounds comprising a xanthene dye based moiety and an alkyl imidazole moiety. Methods of assessing these fluorescent Schiff base compounds as fluorescent probes for metal ions in Cu.sup.2+ chemosensing applications, methods of preparing the fluorescent Schiff base compounds and methods of detecting Cu.sup.2+ ions with the same are also provided.

FLUORESCENT SCHIFF BASE CONJUGATE CU(II) CHEMOSENSORS AND METHODS THEREOF

Fluorescent Schiff base compounds comprising a xanthene dye based moiety and an alkyl imidazole moiety. Methods of assessing these fluorescent Schiff base compounds as fluorescent probes for metal ions in Cu.sup.2+ chemosensing applications, methods of preparing the fluorescent Schiff base compounds and methods of detecting Cu.sup.2+ ions with the same are also provided.

ELECTROSTATIC INK COMPOSITION

Described herein is a yellow liquid electrophotographic ink composition comprising: a thermoplastic resin comprising a polymer having acidic side groups; and a colorant comprising a yellow pigment, wherein the yellow pigment comprises a hydrazone compound. Also described herein is a method of producing a printed substrate using the yellow liquid electrophotographic ink composition and a printed substrate produced therefrom.

ELECTROSTATIC INK COMPOSITION

Described herein is a yellow liquid electrophotographic ink composition comprising: a thermoplastic resin comprising a polymer having acidic side groups; and a colorant comprising a yellow pigment, wherein the yellow pigment comprises a hydrazone compound. Also described herein is a method of producing a printed substrate using the yellow liquid electrophotographic ink composition and a printed substrate produced therefrom.

METHODS TO FORMULATE NEUTRAL ORGANIC COMPOUNDS WITH POLYMER NANOPARTICLES
20220211035 · 2022-07-07 ·

A composition including a collapsed, polymer nanoparticle and at least one organic, neutral compound associated with the nanoparticle, wherein the nanoparticle is less than 100 nm in diameter, and the polymer comprises a water-soluble polyelectrolyte, has a molecular weight of at least about 100,000 Dalton and is cross-linked. The organic, neutral compound is selected from the group consisting of dyes, pigments, colorants, oils, UV-light absorbing molecules, fragrances, flavoring molecules, preservatives, electro-conductive compounds, thermoplastic compounds, adhesion promoters, penetration enhancers, anti-corrosive agents, and combinations thereof.

METHODS TO FORMULATE NEUTRAL ORGANIC COMPOUNDS WITH POLYMER NANOPARTICLES
20220211035 · 2022-07-07 ·

A composition including a collapsed, polymer nanoparticle and at least one organic, neutral compound associated with the nanoparticle, wherein the nanoparticle is less than 100 nm in diameter, and the polymer comprises a water-soluble polyelectrolyte, has a molecular weight of at least about 100,000 Dalton and is cross-linked. The organic, neutral compound is selected from the group consisting of dyes, pigments, colorants, oils, UV-light absorbing molecules, fragrances, flavoring molecules, preservatives, electro-conductive compounds, thermoplastic compounds, adhesion promoters, penetration enhancers, anti-corrosive agents, and combinations thereof.

Aie luminogens for visualization and treatment of cancer

The present subject matter relates to ATE luminogens for visualization and treatment of cancer, particularly AIE luminogenic probes for cancer cell visualization and discrimination, lysosome-targeting AIEgens for imaging and autophagy visualization, highly fluorescent AIE-active theranostic agents for monitoring drug distribution and having anti-tumor activity to specific cancer cells, probes comprising AIE luminogens for cancer cell imaging and staining, AIE luminogens having clusteroluminogenic features and applications thereof, and methods of preparing thereof.

Aie luminogens for visualization and treatment of cancer

The present subject matter relates to ATE luminogens for visualization and treatment of cancer, particularly AIE luminogenic probes for cancer cell visualization and discrimination, lysosome-targeting AIEgens for imaging and autophagy visualization, highly fluorescent AIE-active theranostic agents for monitoring drug distribution and having anti-tumor activity to specific cancer cells, probes comprising AIE luminogens for cancer cell imaging and staining, AIE luminogens having clusteroluminogenic features and applications thereof, and methods of preparing thereof.